New York Valves: The Structural Heart Summit

"New York Valves? This isn't a transcatheter valve meeting. It's not a surgical meeting, either. It's the Heart Valves Disease Meeting, and it's happening in the iconic city of New York!"

Thomas Elie Modine, MD, PhD, MBA

Cardiovascular Surgeon

Professor, Cardiovascular Surgery and Interventional Valve Therapies, Bordeaux University Hospital

Program Director, New York Valves

"As two of the leading groups dedicated to advancing the field of cardiovascular education, the partnership between AATS and CRF® will make New York Valves a comprehensive educational event like no other. I am excited to see colleagues from the entire Heart Team come together as we gather for what is certain to be a globally impactful annual meeting in the capital city of the world. We have had world class meetings focusing primarily on transcatheter valve intervention or surgery, but now we envision the ultimate Heart Team meeting where we will debate, discuss, and move forward together."

David H. Adams, MD, PhD

Marie-Josée and Henry R. Kravis Professor and System Chairman

Department of Cardiovascular Surgery

Icahn School of Medicine at Mount Sinai

Cardiac Surgeon-in-Chief, Mount Sinai Health System

New York Valves Program Director

"NY Valves encourages active interaction with internationally renowned experts to recreate the modern multidisciplinary approach to patients with VHD in the capital city of the world."

Michael A. Borger, MD,PhD

Cardiovascular Surgeon

Director of Cardiac Surgery, Leipzig Heart Center

Program Director, New York Valves

"TVT is now New York Valves. As we've expanded our transcatheter options, it's crucial for us to unite as a heart team—no longer confined to separate interventional and surgery meetings. What's even more significant is that our heart team encompasses cardiovascular imagers and clinicians, such as heart failure and EP experts, along with the APP valve specialists who will play a pivotal role in guiding lifelong management of valve disease. Let's collaborate to establish best practices for post-procedural care to ensure we fulfill our patients' goals!"

Megan Coylewright, MD, MPH

Clinical Cardiologist

Vice Chief of Cardiology and Director, Structural Heart Program, Erlanger Health System

Program Director, New York Valves

"New York Valves 2024 signifies an important milestone for our organization. For the first time, this meeting will provide a unique interactive environment for networking, collaboration, and education, including all members of the heart team. It offers practitioners an unprecedented opportunity to learn about the latest developments in each specific area of our field. Through real multi-specialty collaboration, this summit will not only advance our knowledge but also directly impact patient care worldwide."

Juan F. Granada, MD

Interventional Cardiologist

President and Chief Executive Officer, CRF

Managing Director, New York Valves

"Imaging expertise in the cath lab greatly contributes to the precision and overall success of structural procedures. That’s why we have created a robust imaging track at New York Valves, covering the entire valvular heart disease pathway — from diagnosis to treatment to follow-up — to fill gaps in knowledge for anyone on the structural heart team. It is designed to democratize interventional imaging, with the ultimate goal of improving patient access to core valvular heard disease treatment."

Rebecca T. Hahn, MD

Interventional Echocardiographer

Director of Interventional Echocardiography, Columbia Structural Heart & Valve Center

Program Director, New York Valves

"New York Valves 2024 is more than just a meeting; it's a multidisciplinary movement reshaping the landscape of cardiovascular care in patients with valvular and structural heart disease. From novel therapies to best clinical practices, this summit embodies the evolution of transcatheter and surgical interventions. Our goal is to unite specialists from every corner of cardiovascular care to extend the heart team, redefine innovations, and develop new standards for managing valve patients."

Martin B. Leon, MD

Interventional Cardiologist

Founder and Chairman Emeritus of CRF^®

Managing Director, New York Valves

"NY Valves is the one meeting you want to attend when you are looking to improve your understanding and skillset of structural heart interventions. Meet the surgeons, imagers and interventional cardiologists who are setting the standards for contemporary structural heart interventions and do this in the Big Apple! Let's meet in June in New York!"

Nicolas M. Van Mieghem, MD, PhD

Interventional Cardiologist

Professor and Clinical Director of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Center

Program Director, New York Valves

"New York Valves? This isn't a transcatheter valve meeting. It's not a surgical meeting, either. It's the Heart Valves Disease Meeting, and it's happening in the iconic city of New York!"

Thomas Elie Modine, MD, PhD, MBA

Cardiovascular Surgeon

Professor, Cardiovascular Surgery and Interventional Valve Therapies, Bordeaux University Hospital

Program Director, New York Valves

"As two of the leading groups dedicated to advancing the field of cardiovascular education, the partnership between AATS and CRF® will make New York Valves a comprehensive educational event like no other. I am excited to see colleagues from the entire Heart Team come together as we gather for what is certain to be a globally impactful annual meeting in the capital city of the world. We have had world class meetings focusing primarily on transcatheter valve intervention or surgery, but now we envision the ultimate Heart Team meeting where we will debate, discuss, and move forward together."

David H. Adams, MD, PhD

Marie-Josée and Henry R. Kravis Professor and System Chairman

Department of Cardiovascular Surgery

Icahn School of Medicine at Mount Sinai

Cardiac Surgeon-in-Chief, Mount Sinai Health System

New York Valves Program Director

"NY Valves encourages active interaction with internationally renowned experts to recreate the modern multidisciplinary approach to patients with VHD in the capital city of the world."

Michael A. Borger, MD,PhD

Cardiovascular Surgeon

Director of Cardiac Surgery, Leipzig Heart Center

Program Director, New York Valves

"TVT is now New York Valves. As we've expanded our transcatheter options, it's crucial for us to unite as a heart team—no longer confined to separate interventional and surgery meetings. What's even more significant is that our heart team encompasses cardiovascular imagers and clinicians, such as heart failure and EP experts, along with the APP valve specialists who will play a pivotal role in guiding lifelong management of valve disease. Let's collaborate to establish best practices for post-procedural care to ensure we fulfill our patients' goals!"

Megan Coylewright, MD, MPH

Clinical Cardiologist

Vice Chief of Cardiology and Director, Structural Heart Program, Erlanger Health System

Program Director, New York Valves

"New York Valves 2024 signifies an important milestone for our organization. For the first time, this meeting will provide a unique interactive environment for networking, collaboration, and education, including all members of the heart team. It offers practitioners an unprecedented opportunity to learn about the latest developments in each specific area of our field. Through real multi-specialty collaboration, this summit will not only advance our knowledge but also directly impact patient care worldwide."

Juan F. Granada, MD

Interventional Cardiologist

President and Chief Executive Officer, CRF

Managing Director, New York Valves

"Imaging expertise in the cath lab greatly contributes to the precision and overall success of structural procedures. That’s why we have created a robust imaging track at New York Valves, covering the entire valvular heart disease pathway — from diagnosis to treatment to follow-up — to fill gaps in knowledge for anyone on the structural heart team. It is designed to democratize interventional imaging, with the ultimate goal of improving patient access to core valvular heard disease treatment."

Rebecca T. Hahn, MD

Interventional Echocardiographer

Director of Interventional Echocardiography, Columbia Structural Heart & Valve Center

Program Director, New York Valves

"New York Valves 2024 is more than just a meeting; it's a multidisciplinary movement reshaping the landscape of cardiovascular care in patients with valvular and structural heart disease. From novel therapies to best clinical practices, this summit embodies the evolution of transcatheter and surgical interventions. Our goal is to unite specialists from every corner of cardiovascular care to extend the heart team, redefine innovations, and develop new standards for managing valve patients."

Martin B. Leon, MD

Interventional Cardiologist

Founder and Chairman Emeritus of CRF^®

Managing Director, New York Valves

"NY Valves is the one meeting you want to attend when you are looking to improve your understanding and skillset of structural heart interventions. Meet the surgeons, imagers and interventional cardiologists who are setting the standards for contemporary structural heart interventions and do this in the Big Apple! Let's meet in June in New York!"

Nicolas M. Van Mieghem, MD, PhD

Interventional Cardiologist

Professor and Clinical Director of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Center

Program Director, New York Valves

"New York Valves? This isn't a transcatheter valve meeting. It's not a surgical meeting, either. It's the Heart Valves Disease Meeting, and it's happening in the iconic city of New York!"

Thomas Elie Modine, MD, PhD, MBA

Cardiovascular Surgeon

Professor, Cardiovascular Surgery and Interventional Valve Therapies, Bordeaux University Hospital

Program Director, New York Valves

Secure Your Front-Row Seat to the Future of Valvular and Structural Heart Disease

Exclusive Heart Team Discount!

Redefining Innovation and Multidisciplinary Collaboration in Structural Heart Care

3 Days, 1 Mission:
Shape the Future of Structural Heart Care Together

Experience a Personalized Educational Journey for Every Heart Team Member

Dates To Know

Meet Our Distinguished Program Leadership Team!

A stellar lineup of world-renowned leaders will unite the multidisciplinary heart team — interventional cardiologists, cardiac surgeons, clinical cardiologists, cardiac imagers, and heart failure experts — for a collective impact on the future of heart care.

In Their Own Words: Perspectives From Program Directors

Thomas Elie Modine, MD, PhD, MBA

David H. Adams, MD, PhD

Michael A. Borger, MD,PhD

Megan Coylewright, MD, MPH

Juan F. Granada, MD

Rebecca T. Hahn, MD

Martin B. Leon, MD

Nicolas M. Van Mieghem, MD, PhD

Thomas Elie Modine, MD, PhD, MBA

David H. Adams, MD, PhD

Michael A. Borger, MD,PhD

Megan Coylewright, MD, MPH

Juan F. Granada, MD

Rebecca T. Hahn, MD

Martin B. Leon, MD

Nicolas M. Van Mieghem, MD, PhD

Thomas Elie Modine, MD, PhD, MBA

Secure Your Front-Row Seat to the Future of Valvular and Structural Heart Disease

Exclusive Heart Team Discount!

Redefining Innovation and Multidisciplinary Collaboration in Structural Heart Care

3 Days, 1 Mission: Shape the Future of Structural Heart Care Together

Experience a Personalized Educational Journey for Every Heart Team Member

Dates To Know

Meet Our Distinguished Program Leadership Team!

A stellar lineup of world-renowned leaders will unite the multidisciplinary heart team — interventional cardiologists, cardiac surgeons, clinical cardiologists, cardiac imagers, and heart failure experts — for a collective impact on the future of heart care.

In Their Own Words: Perspectives From Program Directors

David H. Adams, MD, PhD

3 Days, 1 Mission:
Shape the Future of Structural Heart Care Together